Search results
Results from the WOW.Com Content Network
The hypoglossal nerve stimulator is a novel strategy for the treatment of obstructive sleep apnea. [ 1 ] [ 2 ] It has been gaining popularity over the last few decades and was approved in Europe in 2013 and the Food and Drug Administration (FDA) in April 2014. [ 3 ]
The US Food and Drug Administration first approved the hypoglossal nerve stimulator in 2014, and to date the device has been implanted in 60,000 people worldwide, according to the manufacturer. A ...
MORE: US obesity rates drop for 1st time in a decade, with possible help from weight loss medications. ... Obstructive sleep apnea is more common in men than women. Up to 34% of U.S. men have OSA ...
Inspire is a hypoglossal nerve stimulator (HNS) to treat obstructive sleep apnea. It is an implantable device that stimulates nerves controlling the tongue. The device causes the tongue to move ...
Hypoglossal nerve stimulation, an option for some patients who have obstructive sleep apnea [28] Percutaneous tibial nerve stimulation (PTNS) for the treatment of incontinence. Peripheral nerve stimulation (PNS, which refers to simulation of nerves beyond the spine or brain, and may be considered to include occipital or sacral nerve stimulation)
Hypoglossal nerve stimulator This page was last edited on 17 April 2013, at 11:29 (UTC). Text is available under the Creative Commons Attribution-ShareAlike 4 ...
Patients with a common sleep disorder have been fitted with an app-controlled device that zaps the nerves in the tongue to help them breathe overnight in a UK first.
For the first time in over a decade, obesity rates in the United States may finally be heading in the right direction and new weight loss drugs like semaglutide could be part of the reason why. A ...